Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06286956

Rectal Tumor Resection Using the UNI-VEC Multichannel Transanal Access Device

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Vecmedical Spain, S.L. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the clinical trial is to investigate whether the use of a new multichannel endoscopic transanal access device (named UNI-VEC) is safe and effective in the resection of a rectal polyp or tumor that sits in the distal part of the colon (up to about 20 cm from the anal margin). This is the first study to test the device in humans, after proving its good performance in preclinical development (preclinical development has included functional laboratory tests and an animal trial).

Conditions

Interventions

TypeNameDescription
DEVICETreatment of rectal lesions with UNI-VECPolyp resections

Timeline

Start date
2021-04-19
Primary completion
2025-01-03
Completion
2025-05-07
First posted
2024-02-29
Last updated
2025-03-27

Locations

11 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT06286956. Inclusion in this directory is not an endorsement.

Rectal Tumor Resection Using the UNI-VEC Multichannel Transanal Access Device (NCT06286956) · Clinical Trials Directory